Digital River, Inc. provides end-to-end cloud-commerce, payments, and marketing solutions to various companies in the United States, Europe, the Asia Pacific, and South America. Its solution combines a Commerce-as-a-Service commerce technology platform, commerce business infrastructure (CBI), and a suite of services to help businesses to avoid the costs and risks of running an integrated global commerce operation in-house. The company offers various services, including design, development, and hosting of commerce stores; merchandising; order management; fraud prevention screening; processing of popular localized online payment methods; export controls and management; tax compliance and management; digital product delivery via download; physical product fulfillment; multi-lingual customer service; subscription management; online marketing services, such as email marketing; paid search program management; Website optimization; and Web analytics and reporting services, as well as other programs. It also offers payment provider services, including payment gateway services, merchant set-up and training, transaction authorization and electronic draft capture, clearing and settlement, merchant accounting, merchant assistance and support and risk management, and electronic payment processing services. In addition, the company provides paid search advertising, search engine optimization and marketing, affiliate marketing, display advertising, store optimization, and email marketing and optimization services. It serves digital products and cloud services companies; consumer electronics, electronic toys, housewares, medical equipment, power tools, and sporting equipment manufacturers; and channel partners, including retailers and affiliates. The company sells its products and services to consumers through the Internet, as well as through direct sales force. Digital River, Inc. was founded in 1994 and is headquartered in Eden Prairie, Minnesota.
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. The company uses its microRNA product platform to develop anti-miRs, which is chemically modified and single-stranded oligonucleotide. Its clinical candidate products include RG-101, which is a GalNAc-conjugated anti-miR that targets microRNA-122 for the treatment of patients with chronic hepatitis C virus infection. The company has strategic collaboration with Biogen Idec MA Inc. for the evaluation of the use of microRNA signatures as a biomarker for human patients with multiple sclerosis; AstraZeneca AB to discover and develop microRNA therapeutics for cardiovascular diseases, metabolic diseases, and oncology; and GlaxoSmithKline plc to discover and develop microRNA therapeutics for immuno-inflammatory diseases. It also has strategic collaboration with Sanofi for the discovery and development of microRNA therapeutics comprising miR-21 pre-clinical fibrosis program for the treatment of alport syndrome and preclinical program for oncology indications; and preclinical programs targeting miR-221/222 for oncology indications. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.
BJ's Restaurants, Inc. owns and operates casual dining restaurants in the Unites States. The company's restaurants offer pizzas, beers, appetizers, entrees, pastas, sandwiches, salads, and desserts. As of October 7, 2014, it owned and operated 154 casual dining restaurants under the BJ's Restaurant & Brewery, BJ's Restaurant & Brewhouse, BJ's Pizza & Grill, and BJ's Grill brands. The company was founded in 1978 and is based in Huntington Beach, California.
Hudson Valley Holding Corp. operates as the bank holding company for Hudson Valley Bank, N.A. that provides banking and related services to businesses, professionals, municipalities, not-for-profit organizations, and individuals in New York. The company offers various deposit products, including non-interest bearing demand deposit, checking with interest, money market, and savings accounts, as well as various forms of time deposits. It also provides a range of loans that comprise commercial real estate loans; construction loans secured by land for residential and commercial development; residential real estate loans, including 1-4 family residential mortgages, multi-family residential loans, and home equity line of credit products; commercial business loans, and lines of credit; installment loans and reserve lines of credit; and lease financing principally for office equipment, telephone systems, computer systems, energy saving improvements, and other special use equipment. In addition, the company offers investment management and broker-dealer services. Further, it provides a software application to meet the specific administrative needs of bankruptcy trustees through a marketing and licensing agreement with the application vendor. As of April 2, 2014, it operated 28 branches. Hudson Valley Holding Corp. was founded in 1972 and is headquartered in Yonkers, New York.
STRATTEC SECURITY CORPORATION designs, develops, manufactures, and markets automotive access control products. Its products include mechanical locks and keys, electronically enhanced locks and keys, steering column and instrument panel ignition lock housings, power sliding door systems, power lift gate systems, power deck lid systems, door handles, and related products. The company also provides full service and aftermarket support services to its products. STRATTEC SECURITY CORPORATION offers its products under the VAST brand name. It operates in the United States, Canada, Mexico, Europe, South America, Korea, and China. The company offers its products directly, as well as through wholesale distributors, and other marketers and users. STRATTEC SECURITY CORPORATION is headquartered in Milwaukee, Wisconsin.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect patients and clinicians from the risk of infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related services in the United States and Canada. The company supplies electronic ambulatory infusion pumps and associated disposable kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer. It also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps to oncology practices; and provides biomedical certification, maintenance, and repair services for oncology practices, as well as to other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, the company sells various primary and secondary tubing, cassettes, catheters, and other disposable items that are utilized with infusion pumps. Further, it offers pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics. The company delivers local and field-based customer support, as well as operates pump service and repair centers. As of December 31, 2013, it owned a fleet of approximately 20,000 new and used pole mounted and ambulatory pumps. The company was founded in 2005 and is headquartered in Madison Heights, Michigan.
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services, as well as specialized treatments comprising advanced diagnostic services, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology for companion animals; and sells related retail and pharmaceutical products. This segment also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. The Laboratory segment offers testing and consulting services in the areas of chemistry, pathology, endocrinology, serology, hematology, and microbiology, as well as conducts tests specific to particular diseases. This segment serves animal hospitals, animal practices, universities, and other government organizations. The company also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market; provides online and printed communications, professional education, and marketing solutions to the veterinary community; and offers an e-commerce platform for independent animal hospitals, as well as provides consulting and mobile imaging services. As of December 31, 2013, it operated 609 animal hospitals and 56 veterinary diagnostic laboratories. The company also provides its services to veterinary practices, pharmaceutical manufacturers, and the pet owning community. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.
Castle Brands Inc. develops, markets, imports, and sells beverage alcohol products primarily in the United States. Its beverage alcohol categories include rum, whiskey, liqueurs, vodka, tequila, and wine. The company offers its products under the Gosling's rum, Gosling's Stormy Ginger Beer, Gosling's Dark n Stormy ready-to-drink cocktail, Jefferson's, Jefferson's Reserve and Jefferson's Presidential Select bourbons, Jefferson's rye whiskey, Pallini liqueurs, Clontarf Irish whiskey, Knappogue Castle Whiskey, Brady's Irish cream, Boru vodka, Tierras tequila, Celtic Honey liqueur, Castello Mio sambucas, and Gozio amaretto brands through a network of wholesale distributors and state-operated agencies. Castle Brands Inc. is based in New York, New York.
Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug-eluting implants for patients undergoing sinus surgery to treat chronic sinusitis. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November, 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.